| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |